Equity Details
Price & Market Data
Price: $1.74
Daily Change: +$0.0393 / 2.26%
Daily Range: $1.64 - $1.75
Market Cap: $116,204,280
Daily Volume: 903,405
Performance Metrics
1 Week: -12.95%
1 Month: -0.59%
3 Months: -69.51%
6 Months: -63.64%
1 Year: 11.26%
YTD: -74.19%
About PepGen Inc. (PEPG)
Full market details for PepGen Inc. (PEPG). Current price: 1.74, daily change: +$0.0393 / 2.26%. Market cap: 116,204,280. Comprehensive performance data across all periods.
Company Details
Employees: 56
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.